Sorafenib as a potential strategy for refractory pulmonary arterial hypertension
Keywords: مهار کننده چندینز; Multi-kinase inhibitor; Pulmonary arterial hypertension; Pulmonary veno-occlusive disease; Right heart failure; Sorafenib;